← Leaderboards
Rory A. Fisher
University Of Iowa
$7,846,584
Attributed
$7,846,584
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $787.5K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,846,584 · 5
By mechanism
R01$7,846,584 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- Jeffrey E Pessin$38,223,856
- Mark K Santillan$2,069,568
- Douglas Michael Shasby$2,554,895
- Diane C Slusarski$1,460,670
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseGtp-Binding Protein RegulatorsGenesGtp-Binding ProteinsMolecularRgs ProteinsSignal TransductionMediatingInsightLeadPlayResponseMutationMolecular AnalysisMutantMalignant NeoplasmsMemberMalignant Neoplasm Of Urinary BladderDna DamageLinkIn VivoPathogenesisHeterotrimeric Gtp-Binding ProteinsAbnormal Cell
Grant awards (25)
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$401,234
R01 · FY2022 · AA · contact PI
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$386,250
R01 · FY2022 · AA · contact PI
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$401,234
R01 · FY2021 · AA · contact PI
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$401,234
R01 · FY2020 · AA · contact PI
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$386,250
R01 · FY2020 · AA · contact PI
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$399,609
R01 · FY2019 · AA · contact PI
RGS6 in mesolimbic circuits as a therapeutic target for alcohol use disorders$410,381
R01 · FY2018 · AA · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$298,980
R01 · FY2016 · CA · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$298,980
R01 · FY2015 · CA · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$290,011
R01 · FY2014 · CA · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$281,041
R01 · FY2013 · CA · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$298,980
R01 · FY2012 · CA · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$297,000
R01 · FY2010 · GM · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$300,000
R01 · FY2009 · GM · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$207,560
R01 · FY2009 · GM · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$300,000
R01 · FY2008 · GM · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$48,750
R01 · FY2008 · GM · contact PI
Molecular Analysis and Role of RGS6 as a Novel Growth Suppressor$300,000
R01 · FY2007 · GM · contact PI
RGS6 Signaling and Function in Neural Development$316,874
R01 · FY2006 · GM · contact PI
RGS6 Signaling and Function in Neural Development$324,500
R01 · FY2005 · GM
RGS6 Signaling and Function in Neural Development$324,500
R01 · FY2004 · GM
RGS6 Signaling and Function in Neural Development$324,316
R01 · FY2003 · GM
PLATELET ACTIVATING FACTOR SIGNALING IN LIVER$291,370
R01 · FY2002 · HL
PLATELET ACTIVATING FACTOR SIGNALING IN LIVER$282,885
R01 · FY2001 · HL
PLATELET ACTIVATING FACTOR SIGNALING IN LIVER$274,645
R01 · FY2000 · HL